Granulomatosis polyangiitis associated with meningeal involvement: response to rituximab therapy after failure of cyclophosphamide

Wegener’s granulomatosis or granulomatosis polyangiitis associated (GPA) is a granulomatous inflammation of the upper and lower respiratory tracts associated with necrotising vasculitis of small and medium-sized blood vessels and, frequently, necrotising glomerulonephritis. We describe the case of a...

Full description

Bibliographic Details
Main Authors: M. Benucci, F. Li Gobbi, P. Panconesi, M. Manfredi, P. Sarzi-Puttini, F. Atzeni
Format: Article
Language:English
Published: PAGEPress Publications 2013-05-01
Series:Reumatismo
Subjects:
Online Access:http://www.reumatismo.org/index.php/reuma/article/view/645
_version_ 1818246821099601920
author M. Benucci
F. Li Gobbi
P. Panconesi
M. Manfredi
P. Sarzi-Puttini
F. Atzeni
author_facet M. Benucci
F. Li Gobbi
P. Panconesi
M. Manfredi
P. Sarzi-Puttini
F. Atzeni
author_sort M. Benucci
collection DOAJ
description Wegener’s granulomatosis or granulomatosis polyangiitis associated (GPA) is a granulomatous inflammation of the upper and lower respiratory tracts associated with necrotising vasculitis of small and medium-sized blood vessels and, frequently, necrotising glomerulonephritis. We describe the case of a 37 year old female patient presenting with upper respiratory tract involvement, chronic rhinosinusitis with green secretions, and bilateral hypoacusia. Ten months later, she suffered occipital headache and two episodes of lipothymia associated with nausea, photophobia, faintness with visual blurring. Magnetic resonance imaging (MRI) revealed aseptic meningitis. The patient was treated with steroids and cyclophosphamide without any effect on the neurological symptoms which, however, greatly improved after subsequent treatment with rituximab as confirmed by means of cerebral MRI. Rituximab is an optimal means of treating cyclophosphamide-resistant patients with GPA associated with meningeal involvement.
first_indexed 2024-12-12T14:54:54Z
format Article
id doaj.art-ae4467b1f3b74bdeb60aa9ee1af4d723
institution Directory Open Access Journal
issn 0048-7449
2240-2683
language English
last_indexed 2024-12-12T14:54:54Z
publishDate 2013-05-01
publisher PAGEPress Publications
record_format Article
series Reumatismo
spelling doaj.art-ae4467b1f3b74bdeb60aa9ee1af4d7232022-12-22T00:20:56ZengPAGEPress PublicationsReumatismo0048-74492240-26832013-05-01652909410.4081/reumatismo.2013.90602Granulomatosis polyangiitis associated with meningeal involvement: response to rituximab therapy after failure of cyclophosphamideM. Benucci0F. Li Gobbi1P. Panconesi2M. Manfredi3P. Sarzi-Puttini4F. Atzeni5Rheumatology Unit, San Giovanni di Dio Hospital, FlorenceRheumatology Unit, San Giovanni di Dio Hospital, FlorenceRadiology Unit, San Giovanni di Dio Hospital, FlorenceImmunology and Allergology Laboratory, San Giovanni di Dio Hospital, FlorenceRheumatology Unit, L. Sacco University Hospital, MilanRheumatology Unit, L. Sacco University Hospital, MilanWegener’s granulomatosis or granulomatosis polyangiitis associated (GPA) is a granulomatous inflammation of the upper and lower respiratory tracts associated with necrotising vasculitis of small and medium-sized blood vessels and, frequently, necrotising glomerulonephritis. We describe the case of a 37 year old female patient presenting with upper respiratory tract involvement, chronic rhinosinusitis with green secretions, and bilateral hypoacusia. Ten months later, she suffered occipital headache and two episodes of lipothymia associated with nausea, photophobia, faintness with visual blurring. Magnetic resonance imaging (MRI) revealed aseptic meningitis. The patient was treated with steroids and cyclophosphamide without any effect on the neurological symptoms which, however, greatly improved after subsequent treatment with rituximab as confirmed by means of cerebral MRI. Rituximab is an optimal means of treating cyclophosphamide-resistant patients with GPA associated with meningeal involvement.http://www.reumatismo.org/index.php/reuma/article/view/645Granulomatosis polyangiitis associated, Rituximab
spellingShingle M. Benucci
F. Li Gobbi
P. Panconesi
M. Manfredi
P. Sarzi-Puttini
F. Atzeni
Granulomatosis polyangiitis associated with meningeal involvement: response to rituximab therapy after failure of cyclophosphamide
Reumatismo
Granulomatosis polyangiitis associated, Rituximab
title Granulomatosis polyangiitis associated with meningeal involvement: response to rituximab therapy after failure of cyclophosphamide
title_full Granulomatosis polyangiitis associated with meningeal involvement: response to rituximab therapy after failure of cyclophosphamide
title_fullStr Granulomatosis polyangiitis associated with meningeal involvement: response to rituximab therapy after failure of cyclophosphamide
title_full_unstemmed Granulomatosis polyangiitis associated with meningeal involvement: response to rituximab therapy after failure of cyclophosphamide
title_short Granulomatosis polyangiitis associated with meningeal involvement: response to rituximab therapy after failure of cyclophosphamide
title_sort granulomatosis polyangiitis associated with meningeal involvement response to rituximab therapy after failure of cyclophosphamide
topic Granulomatosis polyangiitis associated, Rituximab
url http://www.reumatismo.org/index.php/reuma/article/view/645
work_keys_str_mv AT mbenucci granulomatosispolyangiitisassociatedwithmeningealinvolvementresponsetorituximabtherapyafterfailureofcyclophosphamide
AT fligobbi granulomatosispolyangiitisassociatedwithmeningealinvolvementresponsetorituximabtherapyafterfailureofcyclophosphamide
AT ppanconesi granulomatosispolyangiitisassociatedwithmeningealinvolvementresponsetorituximabtherapyafterfailureofcyclophosphamide
AT mmanfredi granulomatosispolyangiitisassociatedwithmeningealinvolvementresponsetorituximabtherapyafterfailureofcyclophosphamide
AT psarziputtini granulomatosispolyangiitisassociatedwithmeningealinvolvementresponsetorituximabtherapyafterfailureofcyclophosphamide
AT fatzeni granulomatosispolyangiitisassociatedwithmeningealinvolvementresponsetorituximabtherapyafterfailureofcyclophosphamide